Cadre Holdings, Inc. Cost of Revenue
Cadre Holdings, Inc. (CDRE) reported Cost of Revenue of $119.99 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-05
- Cadre Holdings, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $119.99M, a 29.22% increase year-over-year.
- Cadre Holdings, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $95.26M, a 28.78% increase year-over-year.
- Cadre Holdings, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $94.60M, a 4.25% decline year-over-year.
- Cadre Holdings, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $89.24M, a 28.61% increase year-over-year.
- Cadre Holdings, Inc. cost of goods and services sold for fiscal 2025 was $350.68M, a 4.97% increase from fiscal 2024.
- Cadre Holdings, Inc. cost of goods and services sold for fiscal 2024 was $334.08M, a 18.55% increase from fiscal 2023.
- Cadre Holdings, Inc. cost of goods and services sold for fiscal 2023 was $281.81M, a 0.13% decline from fiscal 2022.
- Cadre Holdings, Inc. cost of goods and services sold for fiscal 2022 was $282.16M, a 9.96% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $119.99M 10-Q · filed 2026-08-05 | $215.25M 10-Q · filed 2026-08-05 | $309.86M derived: sum of 3 quarters · filed 2026-08-05 | $399.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $95.26M 10-Q · filed 2026-05-11 | $189.86M derived: sum of 2 quarters · filed 2026-05-11 | $279.11M derived: sum of 3 quarters · filed 2026-05-11 | $371.97M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $94.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $183.84M derived: sum of 2 quarters · filed 2026-03-10 | $276.70M derived: sum of 3 quarters · filed 2026-08-05 | $350.68M 10-K · filed 2026-03-10 |
| 2025-09-30 | $89.24M 10-Q · filed 2025-11-04 | $182.10M derived: sum of 2 quarters · filed 2026-08-05 | $256.08M 10-Q · filed 2025-11-04 | $354.88M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $92.86M 10-Q · filed 2026-08-05 | $166.84M 10-Q · filed 2026-08-05 | $265.63M derived: sum of 3 quarters · filed 2026-08-05 | $335.02M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $73.97M 10-Q · filed 2026-05-11 | $172.77M derived: sum of 2 quarters · filed 2026-05-11 | $242.16M derived: sum of 3 quarters · filed 2026-05-11 | $327.82M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $98.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $168.19M derived: sum of 2 quarters · filed 2026-03-10 | $253.85M derived: sum of 3 quarters · filed 2026-03-10 | $334.08M 10-K · filed 2026-03-10 |
| 2024-09-30 | $69.39M 10-Q · filed 2025-11-04 | $155.05M derived: sum of 2 quarters · filed 2025-11-04 | $235.28M 10-Q · filed 2025-11-04 | $310.11M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-06-30 | $85.66M 10-Q · filed 2025-08-05 | $165.89M 10-Q · filed 2025-08-05 | $240.72M derived: sum of 3 quarters · filed 2026-03-10 | $312.23M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-03-31 | $80.23M 10-Q · filed 2025-05-06 | $155.06M derived: sum of 2 quarters · filed 2026-03-10 | $226.57M derived: sum of 3 quarters · filed 2026-03-10 | $296.91M derived: sum of 4 quarters · filed 2026-03-10 |
| 2023-12-31 | $74.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $146.34M derived: sum of 2 quarters · filed 2026-03-10 | $216.68M derived: sum of 3 quarters · filed 2026-03-10 | $281.81M 10-K · filed 2026-03-10 |
| 2023-09-30 | $71.51M 10-Q · filed 2024-11-06 | $141.85M derived: sum of 2 quarters · filed 2024-11-06 | $206.98M 10-Q · filed 2024-11-06 | $282.10M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | $70.34M 10-Q · filed 2024-08-09 | $135.47M 10-Q · filed 2024-08-09 | $210.59M derived: sum of 3 quarters · filed 2025-03-11 | $278.40M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $65.13M 10-Q · filed 2024-05-08 | $140.25M derived: sum of 2 quarters · filed 2025-03-11 | $208.06M derived: sum of 3 quarters · filed 2025-03-11 | $283.07M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $75.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $142.93M derived: sum of 2 quarters · filed 2025-03-11 | $217.94M derived: sum of 3 quarters · filed 2025-03-11 | $282.16M 10-K · filed 2025-03-11 |
| 2022-09-30 | $67.81M 10-Q · filed 2023-11-08 | $142.82M derived: sum of 2 quarters · filed 2023-11-08 | $207.04M 10-Q · filed 2023-11-08 | $271.38M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-06-30 | $75.01M 10-Q · filed 2023-08-08 | $139.23M 10-Q · filed 2023-08-08 | $203.57M derived: sum of 3 quarters · filed 2024-03-12 | $262.92M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-03-31 | $64.22M 10-Q · filed 2023-05-09 | $128.56M derived: sum of 2 quarters · filed 2024-03-12 | $187.91M derived: sum of 3 quarters · filed 2024-03-12 | $254.24M derived: sum of 4 quarters · filed 2024-03-12 |
| 2021-12-31 | $64.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $123.69M derived: sum of 2 quarters · filed 2024-03-12 | $190.02M derived: sum of 3 quarters · filed 2024-03-12 | $256.60M 10-K · filed 2024-03-12 |
| 2021-09-30 | $59.35M 10-Q · filed 2022-11-10 | $125.68M derived: sum of 2 quarters · filed 2022-11-10 | $192.26M 10-Q · filed 2022-11-10 | $260.09M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $66.33M 10-Q · filed 2022-08-11 | $132.91M 10-Q · filed 2022-08-11 | $200.75M derived: sum of 3 quarters · filed 2022-08-11 | $266.48M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $66.58M 10-Q · filed 2022-05-16 | $134.41M derived: sum of 2 quarters · filed 2022-05-16 | $200.15M derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $67.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $133.57M derived: sum of 2 quarters · filed 2022-03-11 | $251.70M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $65.74M 10-Q · filed 2021-12-02 | $183.87M 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |